3,277 Shares of Agilent Technologies, Inc. $A Bought by Stolz & Associates PS

Stolz & Associates PS bought a new stake in shares of Agilent Technologies, Inc. (NYSE:A) in the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 3,277 shares of the medical research company’s stock, valued at approximately $565,000. Agilent Technologies accounts for 0.3% of Stolz & Associates PS’s investment portfolio, making the stock its 21st largest position.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bank of New York Mellon Corp boosted its position in shares of Agilent Technologies by 87.4% during the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after buying an additional 2,440,360 shares during the period. Legal & General Group Plc acquired a new stake in Agilent Technologies in the 2nd quarter valued at approximately $260,101,000. Bank of America Corp DE acquired a new stake in Agilent Technologies in the 2nd quarter valued at approximately $213,269,000. Man Group plc acquired a new stake in Agilent Technologies in the 2nd quarter valued at approximately $179,257,000. Finally, Primecap Management Co. CA acquired a new stake in Agilent Technologies in the 2nd quarter valued at approximately $176,318,000.

Insiders Place Their Bets

In related news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $151.38, for a total transaction of $95,974.92. Following the transaction, the director directly owned 4,924 shares of the company’s stock, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Agilent Technologies Price Performance

NYSE A opened at $178.02 on Wednesday. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $182.99. The firm has a market capitalization of $50.19 billion, a PE ratio of 35.04, a P/E/G ratio of 2.64 and a beta of 1.24. The company’s 50 day simple moving average is $166.93 and its 200 day simple moving average is $137.60. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping analysts’ consensus estimates of $1.49 by $0.13. The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 6.20 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 28th. Investors of record on Tuesday, October 6th were paid a dividend of $0.2550 per share. The ex-dividend date of this dividend was Tuesday, October 6th. This represents a $1.02 annualized dividend and a yield of 0.6%. Agilent Technologies’s dividend payout ratio (DPR) is currently 20.08%.

Analyst Ratings Changes

A number of brokerages have issued reports on A. Barclays boosted their price target on Agilent Technologies from $175.00 to $195.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 7th. Evercore raised their price target on Agilent Technologies from $148.00 to $178.00 and gave the company an “outperform” rating in a report on Wednesday, October 7th. JPMorgan Chase & Co. lifted their price objective on shares of Agilent Technologies from $190.00 to $195.00 in a research note on Wednesday, October 14th. Stifel Nicolaus lifted their price objective on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday, August 27th. Finally, Bank of America upped their price objective on shares of Agilent Technologies from $180.00 to $190.00 in a report on Friday, October 9th. Eighteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $181.45.

Agilent Technologies Company Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.